| Identification | Back Directory | [Name]
Laquinimod | [CAS]
248282-07-7 | [Synonyms]
TV 5600 Laquinimod LaquinimodSodium ABR 215062 SodiuM LaquiniMod SodiuM Salt 5-Chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-Methyl-2-oxo-N-phenyl-3-quinolinecarboxaMide SodiuM Salt N-Ethyl-N-phenyl-1,2-dihydro-4-
hydroxy-5-chloro-1-Methyl-2-oxoquinoline-3-carboxaMide SodiuM Salt | [Molecular Formula]
C19H18ClN2NaO3 | [MDL Number]
MFCD25976425 | [MOL File]
248282-07-7.mol | [Molecular Weight]
380.8 |
| Hazard Information | Back Directory | [Uses]
Laquinimod is an oral drug used for treatment of lupus arthritis. | [in vivo]
Laquinimod sodium treatment inhibits donor myelin-specific T cells from transferring EAE to naive recipient mice. In vivo laquinimod treatment alters subpopulations of myeloid antigen presenting cells (APC) that include a decrease in CD11c+CD11b+CD4+dendritic cells (DC) and an elevation of CD11bhiGr1hi monocytes[1]. | [IC 50]
NF-κB |
|
| Company Name: |
J & K SCIENTIFIC LTD.
|
| Telephone: |
18210857532 18210857532 |
| Website: |
https://www.jkchemical.com |
|